Worldwide Cell and Gene Therapy Industry to 2030 - Players Include Amgen, Biogen and Bluebird Bio Among Others

Corporate Breaking News

Home : Worldwide Cell and Gene Therapy Industry to 2030 - Players Include Amgen, Biogen and Bluebird Bio Among Others

Mar 24 2022	Worldwide Cell and Gene Therapy Industry to 2030 - Players Include Amgen, Biogen and Bluebird Bio Among Others
DUBLIN, March 24, 2022 /PRNewswire/ -- The "Cell and Gene Therapy World Market and Market Potential" report has been added to ResearchAndMarkets.com's offering. The report examines developments in cell and gene therapy markets by condition/disorder, including principal products, trends in...


Source:https://www.prnewswire.com:443/news-releases/worldwide-cell-and-gene-therapy-industry-to-2030---players-include-amgen-biogen-and-bluebird-bio-among-others-301509830.html

Related News
» Global Desalination Technologies Market to Reach $22.5 Billion by 2026 » U.S. plant-based food retail sales hit $7.4 billion, outpacing total retail sales, despite supply chain interruptions and pandemic restrictions creating widespread volatility in the food industry